Effects of ozone exposure on house dust mites

Isaac Seow1, Zhen Yun Siew2, Boon Xuan U3

  • 1Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, 43500, Semenyih, Malaysia. hyxis1@nottingham.edu.my.

Scientific Reports
|June 22, 2026
PubMed

Insights

Ozone exposure degrades house dust mite (HDM) allergens like Der f 1 and alters their surface bacteria. HDMs avoid ozone, showing reduced mobility and increased mortality, indicating ozone

Area of Science:

  • Environmental Science
  • Allergen Research
  • Microbiology

Background:

  • House dust mites (HDMs) are major allergens linked to asthma and allergic rhinitis.
  • Effective allergen removal is vital for managing allergic diseases.
  • Dermatophagoides farinae is a predominant HDM species.

Purpose of the Study:

  • To investigate the impact of ozone exposure on Dermatophagoides farinae.
  • To assess ozone's effects on mite allergenicity, microbial communities, mortality, and behavior.

Main Methods:

  • Controlled ozone exposure of D. farinae at varying concentrations (0.05-1 ppm) and durations (24-72 h).
  • Western blotting to quantify Der f 1 and Blo t 5 allergen levels.
  • 16S rRNA sequencing for surface bacterial community analysis.
  • Mortality assays and a three-chamber mobility test to assess behavior.

Main Results:

  • Ozone exposure reduced Der f 1 protein intensity in a dose- and time-dependent manner.
  • Significant shifts in surface bacterial composition were observed post-ozone exposure.
  • Mite mortality increased with higher ozone concentrations and longer exposure times.
  • HDMs exhibited avoidance behavior, preferring non-ozone environments.

Conclusions:

  • Ozone exposure impacts D. farinae at molecular, microbial, and behavioral levels.
  • Ozone shows potential for modulating HDM allergenicity and mite ecology.
  • Further research could explore ozone's application in allergen control strategies.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...